Analyst Ratings for Acceleron Pharma (XLRN)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
10/7/2021 | Jefferies | Akash Tewari | New Coverage | Hold (N/A) |
180.00 (N/A) |
177.13 (178.75) |
0.91% | Details |
10/4/2021 | Raymond James | Danielle Brill | Downgrade | Market Perform (Strong Buy) |
N/A (N/A) |
174.35 (178.75) |
2.52% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |